Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for November 13th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 13th:

Alkermes plc (ALKS - Free Report) : This biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.4% over the last 60 days.

Alkermes’ shares gained 11.3% over the last one month above the S&P 500’s increase 4.2%. The company possesses a Momentum Score of A.

Synaptics Incorporated (SYNA - Free Report) : This company that develops, markets, and sells intuitive human interface solutions for electronic devices and products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.3% over the last 60 days.

Synaptics’ shares gained nearly 49% over the last one month. The company possesses a Momentum Score of A.

Verso Corporation (VRS - Free Report) : This company that produces and sells coated papers in North America has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 1.8% over the last 60 days.

Verso’s shares gained 42.4% over the last one month. The company possesses a Momentum Score of A.

Fortinet, Inc. (FTNT - Free Report) : This company that provides broad, integrated, and automated cybersecurity solutions worldwide has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.2% over the last 60 days.

Fortinet’s shares gained 26.1% over the last one month. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Verso Corporation (VRS) - free report >>

Synaptics Incorporated (SYNA) - free report >>

Fortinet, Inc. (FTNT) - free report >>

Alkermes plc (ALKS) - free report >>